Bank Of America Corp Acorda Therapeutics Inc Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.61 - $2.5 $48,945 - $76,002	-30,401 Reduced 100.0%	1 $0
Q4 2021 Feb 08, 2022	BUY	$2.3 - $4.71 $25,242 - $51,692	10,975 Added 56.49%	30,402 $73,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.79 $64,680 - $92,207	19,250 Added 10875.71%	19,427 $89,000
Q2 2021 Sep 13, 2021	BUY	$3.61 - $5.23 $638 - $925	177 New	177 $1,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.